Fundraising Fox
/Companies
Sign in

Pharmacelera

Barcelona, ES · Founded 2015 · 28 employees on LinkedIn · 3 known investors

Find your way into Pharmacelera

Each arrow is one introduction. Sign up to fill in the first one.

452 people can intro you to Enric

Ask Raf Roelands to introduce you to Enric Herrero

You →Raf · together at Pharmacelera →Enric

233 people can intro you to Enric

Ask Jamie Chen to introduce you to Enric Gibert

You →Jamie · together at Pharmacelera →Enric

Sign up to find every way you can get introduced to Pharmacelera

  • Your email: who you already know at Pharmacelera, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pharmacelera team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds. It serves small biotech companies, big pharma R&D departments, public research institutions, and CROs across stages from target identification to lead optimization.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Pharmacelera was founded in 2015 by Enric Gibert and Enric Herrero.

EGEnric Gibert
Enric GibertCo Founder and CEOEnric Gibert holds a PhD in computer engineering from Universitat Politècnica de Catalunya and spent a decade at Intel Barcelona Research Center leading high-performance computing architecture teams. He subsequently completed a business degree from IESE Business School and founded Pharmacelera, where he serves as co-founder and CEO.
EHEnric Herrero
Enric HerreroCTO and Co FounderEnric Herrero is co-founder of Pharmacelera, which develops computational chemistry software for drug discovery using quantum mechanics-based molecular descriptors and machine learning. He holds 13 issued patents and has published research in top-tier conferences and journals in the field.

Investors · 3

GENERAL INCEPTIONlisted by GENERAL INCEPTIONPalo Alto

How we know: GENERAL INCEPTION's portfolio page · Not right? Tell us

Heran Partnerslisted by Heran PartnersAntwerp

In the news

Pharmacelera Raises €6M in Fundingfinsmes.com · Feb 2026Pharmacelera raises €6M to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform | Pharmacelerapharmacelera.com · Feb 2026Funding sources | Pharmacelerapharmacelera.com · Mar 2025

Frequently asked questions

What does Pharmacelera do?
Pharmacelera develops computational chemistry software and services for drug discovery, using proprietary 3D molecular field descriptors, quantum mechanics, and AI to screen ultra-large chemical libraries and identify novel, synthesizable compounds. It serves small biotech companies, big pharma R&D departments, public research institutions, and CROs across stages from target identification to lead optimization.
Who founded Pharmacelera?
Pharmacelera was founded by Enric Gibert, Enric Herrero in 2015.
Who are Pharmacelera's investors?
Pharmacelera's investors include Capital Cell, GENERAL INCEPTION, Heran Partners.
Where is Pharmacelera headquartered?
Pharmacelera is headquartered in Barcelona, ES.